Article
Chromatin remodeling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin.
The Journal of pharmacology and experimental therapeutics - 1 May 2013
Lesma Elena, Ancona Silvia, Orpianesi Emanuela, Grande Vera, Di Giulio Anna Maria, Gorio Alfredo
Abstract excerpt
Tuberous sclerosis complex (TSC) is a multi-systemic syndrome caused by mutations in TSC1 or TSC2 gene. In TSC2-null cells, Rheb, a member of the Ras family of GTPases, is constitutively activated. Statins inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase and block the synthesis of isoprenoid lipids with inhibition of Rheb farnesylation and RhoA geranylgeranylation. The effects of rosuvastatin on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
